Correlation Between Alvotech and Oramed Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Alvotech and Oramed Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Alvotech and Oramed Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Alvotech and Oramed Pharmaceuticals, you can compare the effects of market volatilities on Alvotech and Oramed Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Alvotech with a short position of Oramed Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Alvotech and Oramed Pharmaceuticals.
Diversification Opportunities for Alvotech and Oramed Pharmaceuticals
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Alvotech and Oramed is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Alvotech and Oramed Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Oramed Pharmaceuticals and Alvotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Alvotech are associated (or correlated) with Oramed Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Oramed Pharmaceuticals has no effect on the direction of Alvotech i.e., Alvotech and Oramed Pharmaceuticals go up and down completely randomly.
Pair Corralation between Alvotech and Oramed Pharmaceuticals
Given the investment horizon of 90 days Alvotech is expected to under-perform the Oramed Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Alvotech is 1.58 times less risky than Oramed Pharmaceuticals. The stock trades about -0.12 of its potential returns per unit of risk. The Oramed Pharmaceuticals is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest 234.00 in Oramed Pharmaceuticals on September 13, 2024 and sell it today you would earn a total of 14.50 from holding Oramed Pharmaceuticals or generate 6.2% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Alvotech vs. Oramed Pharmaceuticals
Performance |
| Timeline |
| Alvotech |
| Oramed Pharmaceuticals |
Alvotech and Oramed Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Alvotech and Oramed Pharmaceuticals
The main advantage of trading using opposite Alvotech and Oramed Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Alvotech position performs unexpectedly, Oramed Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Oramed Pharmaceuticals will offset losses from the drop in Oramed Pharmaceuticals' long position.| Alvotech vs. Puma Biotechnology | Alvotech vs. Iovance Biotherapeutics | Alvotech vs. Sarepta Therapeutics | Alvotech vs. Day One Biopharmaceuticals |
| Oramed Pharmaceuticals vs. Protalix Biotherapeutics | Oramed Pharmaceuticals vs. Corvus Pharmaceuticals | Oramed Pharmaceuticals vs. Aldeyra | Oramed Pharmaceuticals vs. Checkpoint Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |